
“Almost Unbelievable in Their Brazenness”: The $45 Million Medicare Botox Fraud That Ended in 15 Years in Prison
She billed for days her clinic was closed, while she was on vacation, and for a patient who was in federal prison.
By Kate Dee, MD — Founder, MedSpa Board
Cosmetic Botox is cash-pay. It always has been. Medicare does not pay to soften a forehead line or a crow’s foot, and neither does any insurer. Medicare pays for onabotulinumtoxinA only when it treats a documented medical condition, and chronic migraine is one of the few on that list.
On October 29, 2026, a federal judge in Los Angeles sentenced Dr. Violetta Mailyan, 45, of Glendale, California, to 15 years in federal prison. A jury had convicted her in May of nine counts of wire fraud and three counts of obstructing a criminal investigation of a health care offense. Prosecutors proved she billed Medicare more than $45 million for Botox injections that were never given, were given only for cosmetic reasons, or went to patients whose primary care physicians had never referred them for migraine treatment. The court ordered her to pay $32,904,049.41 in restitution to Medicare and to forfeit more than $16 million in seized real estate, securities, bank funds and personal property.
In sentencing her, the court called the fraud “truly breathtaking in scope and shocking in its duration” and her actions “almost unbelievable in their brazenness.” The FBI called it the largest Botox fraud scheme in the United States.
She was not an unlicensed operator. She was a licensed physician who owned the clinic, and she used that license to bill Medicare for years. Everyone in this industry who holds a license should sit with that.
Healthy Way Medical Center sold beauty services and billed Medicare for migraine care
Mailyan owned and operated Healthy Way Medical Center in Glendale. According to the Department of Justice, it was a clinic that purported to provide beauty and cosmetic services. Then it billed the federal government as if it were a headache center.
The evidence at trial showed that Mailyan fabricated patient medical records, including consent forms, to make it look as though patients suffered from chronic migraines and had been treated for them in her office. The Justice Department’s fraud chief put it in one line: she “falsely diagnosed patients.” She also backdated claims, billing for injections supposedly given before the patients had even called the clinic to ask for an appointment.
Think about what that means for the people on the other end of those charts. A patient who came in for a cosmetic treatment, or never came in at all, now has a chronic migraine diagnosis in a medical record and a Medicare claims history to match. The public record does not say whether those patients knew.
$19 million billed on days the clinic was closed, and $34,560 on one day she spent in Cabo
Her billing did not survive contact with a calendar. Prosecutors showed she billed for thousands of injections, worth more than $19 million, on days Healthy Way was closed.
She also billed for injecting patients in Glendale while she was on vacation in Cabo, Maui, Las Vegas, Pennsylvania and New York. The Cabo trips alone accounted for more than $200,000 in claims. Prosecutors showed the jury a photograph from her own phone, sent from Cabo on a day she billed Medicare $34,560 for services supposedly performed in California.
She billed for treating a Medicare beneficiary who was in federal prison on the date of the claimed injections.
The money went where you would expect. The jury found that fraud proceeds paid for a Tesla Model X, a Tesla Cybertruck and California real estate, and prosecutors showed she spent it on luxury purchases, including a $12,000 17th-century crossbow and a $3,000 painting.
After a grand jury subpoena, she rewrote patient charts and handed them to federal agents
When the grand jury subpoenaed her medical records, Mailyan did not produce them. She altered them first. According to the evidence at trial, she changed patient records to make it appear she had given Botox for chronic migraines when those services had not been provided, and forged Medicare beneficiary signatures, including the signature of the man who was in federal prison. Then she gave the altered records to federal agents, intending to throw them off her trail.
That is where the three obstruction counts came from. Doctoring a chart after the fact is its own federal crime, separate from the billing, and each count carries up to five years. A falsified record does not hide fraud. It becomes a second piece of evidence of it.
Medicare’s payment data flagged her: $24 million in four years, six times the next highest group
No patient complaint or whistleblower started this case. A spreadsheet did. The investigation began with a referral from the Health Care Fraud Section’s Data Analytics Team, which found that Medicare had paid Mailyan more for Botox injections than any other doctor in the United States. At the time, she had been paid more than $24 million over the previous four years, six times the next highest group of providers, all of them neurologists.
A cosmetic clinic out-billing every neurologist in the country for migraine treatment is not a subtle signal. Federal analysts now run that kind of comparison routinely across Medicare claims, and the Justice Department said so directly when announcing the verdict: its data-driven approach is meant to ensure “no doctor can engage in these types of brazen schemes.”
This is the same direction regulators are moving on product. In April, the FDA sent a warning letter to a Texas medspa whose patient records showed far more Botox administered than it had ever purchased from the manufacturer. Regulators are reconciling records against each other: invoices against charts, claims against calendars, signatures against prison rosters. The practice whose records disagree with each other is the practice that gets a visit.
Medicare pays for Botox only for specific medical conditions, and never for a cosmetic treatment
Here is the federal framework, stated flatly.
Medicare covers botulinum toxin only when it is medically necessary for an FDA-approved medical indication, such as chronic migraine, cervical dystonia, severe underarm sweating, overactive bladder or spasticity. Cosmetic use is excluded.
Chronic migraine has a specific definition for coverage purposes: 15 or more headache days a month, at least eight of them migraine, for at least three months, with documented failure of other preventive medications first. A patient who wants her frown lines treated and mentions she gets headaches does not meet that standard.
Billing a cosmetic injection as a medical one is not a coding error or a gray area. It is a false claim. When it involves Medicare, it is a federal crime, and every claim submitted can be its own count. The same logic applies to private insurers under state law.
Most medspas never bill insurance, and cosmetic Botox is never billable
Most medspas never deal with insurance at all. Cosmetic treatment is cash-pay, the patient pays at checkout, and no claim is ever filed. Nothing in this case changes how those practices operate.
For the few practices that do bill insurance for toxin, the rule is short. A documented medical condition that meets the payer’s criteria, such as chronic migraine or severe underarm sweating, can be billed. A cosmetic treatment cannot be billed, ever. Billing a cosmetic injection as a medical one, billing for a treatment that never happened, or rewriting a chart to support a claim is fraud.
Patients: if you paid cash for cosmetic Botox, it should never appear on a Medicare or insurance statement. If it does, or you see a migraine diagnosis you were never given, report it to the HHS Office of Inspector General at 1-800-HHS-TIPS or oig.hhs.gov.
MedSpa Board certification verifies the oversight and records behind every treatment
No certification can stop a determined fraudster, and none should claim to. What MedSpa Board certification does is verify the things this case turned on before anyone else has to: that a medical director provides active oversight, that every provider practices within the scope of their license, that every product comes from a traceable, FDA-approved source, and that patient records and consent meet the standards a medical practice is held to. Legitimate practices get lumped in with cases like this one. Certification is how they show the difference.
If you run a medspa and your standards are ready to be verified, begin your application now. If you want to see where you stand first, download our free checklist that tells you all the requirements to become certified.
— Kate Dee, MD
Sources & further reading
- U.S. Department of Justice, Office of Public Affairs, “Botox Fraud Doctor Sentenced to 15 Years in Prison for $45M Medicare Scheme,” October 30, 2026. https://www.justice.gov/opa/pr/botox-fraud-doctor-sentenced-15-years-prison-45m-medicare-scheme
- U.S. Department of Justice, Office of Public Affairs, “California Doctor Convicted of $45M Botox Fraud Scheme Targeting Medicare,” May 19, 2026. https://www.justice.gov/opa/pr/california-doctor-convicted-45m-botox-fraud-scheme-targeting-medicare
- U.S. Department of Justice, Office of Public Affairs, “Doctor Indicted for Orchestrating $45M Botox Fraud Scheme Targeting Medicare,” December 18, 2025. https://www.justice.gov/opa/pr/doctor-indicted-orchestrating-45m-botox-fraud-scheme-targeting-medicare
- Dean Fioresi, “LA County doctor sentenced to 15 years in prison for $45 million Botox injection fraud scheme,” CBS Los Angeles, October 30, 2026. https://www.cbsnews.com/losangeles/news/glendale-los-angeles-county-doctor-medicare-fraud-botox-injections-violetta-mailyan/
- WTOP, “Does Medicare Cover Botox?” May 2026. https://wtop.com/news/2026/05/does-medicare-cover-botox/
- U.S. Food and Drug Administration, Warning Letter 723267 to Pure Indulgence Aesthetics, April 1, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pure-indulgence-aesthetics-723267-04012026
- HHS Office of Inspector General, Report Fraud. https://oig.hhs.gov/fraud/report-fraud/
- The MedSpa Board, “Three Colorado Medspa Patients sickened after non-FDA-approved toxin purchased online,” October 2026. https://blog.medspaboard.com/post/colorado-medspa-patients-sickened-unapproved-toxin-bought-online

